United States Securities and Exchange Commission
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(check one)
_X_ Form 10-K
___ Form 20-F
___ Form 11-K
___ Form 10-Q
___ Form N-SAR
For Period Ended : November 30, 2008
___ Transition Report on Form 10-K
___ Transition Report on Form 20-F
___ Transition Report on Form 11-K
___ Transition Report on Form 10-Q
___ Transition Report on Form N-SAR
For the Transition Period Ended: _____________________________________
**********************************************************************
PART 1 - REGISTRANT INFORMATION
Full Name of Registrant: Viropro, Inc.
Address of Principal Executive Office: 8515 Place Devonshire Suite 207
City, State and Zip Code: Montreal, Quebec, Canada H4P 2K1
PART II - RULES 12B-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to rule 12b-25(b){section
23,047], the following should be completed. (Check box if appropriate)
_X_ (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable
effort or expense;
_X_ (b) The subject annual report, semi-annual report, transition
report, on Form 10-K, 10-KSB, Form 20-F, 11-K, Form N-SAR,
or portion thereof will be filed on or before the fifteenth
calendar day following the prescribed due date; or the
subject quarterly report on Form 10-Q, 10-QSB, or portion
there of will be filed on or before the fifth calendar day
following the prescribed due day; and
(c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail why the Form 10-K and Form 10-KSB, 11-K,
10-Q and Form 10QSB, N-SAR, or the transition report or portion thereof,
could not be filed within the prescribed time period.
Audited financial statements have not yet been completed by the Company's
auditors. The auditors indicate the completed statements should be
available within the extension period to allow for timely filing.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Claude Gingras (514) 465-2722
(Name) (Area Code) (Number)
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports)
been filed? If the answer is no, identify report(s).
_X_ Yes ___ No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report
or portion thereof?
___ Yes _X_ No
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
************************************************************************
SIGNATURE
************************************************************************
VIROPRO, INC.
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
By: /s/ Claude Gingras Date: February 27, 2009
_____________________________________ ______________________________
Title: Vice-President, Director
Viropro (CE) (USOTC:VPRO)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Viropro (CE) (USOTC:VPRO)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
